Formycon AG (FYB.DE)

EUR 53.4

(2.5%)

Revenue Summary of Formycon AG

  • Formycon AG's latest annual revenue in 2023 was 77.69 Million EUR , up 82.83% from previous year.
  • Formycon AG's latest quarterly revenue in 2024 Q2 was 26.89 Million EUR , down 0.0% from previous quarter.
  • Formycon AG reported a annual revenue of 42.49 Million EUR in annual revenue 2022, up 16.07% from previous year.
  • Formycon AG reported a annual revenue of 36.61 Million EUR in annual revenue 2021, up 6.97% from previous year.
  • Formycon AG reported a quarterly revenue of 43.78 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • Formycon AG reported a quarterly revenue of 33.9 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of Formycon AG (2023 - 2009)

Historical Annual Revenue of Formycon AG (2023 - 2009)

Year Revenue Revenue Growth
2023 77.69 Million EUR 82.83%
2022 42.49 Million EUR 16.07%
2021 36.61 Million EUR 6.97%
2020 34.22 Million EUR 3.23%
2019 33.15 Million EUR -22.88%
2018 42.99 Million EUR 48.24%
2017 29 Million EUR 48.48%
2016 19.53 Million EUR 15.41%
2015 16.92 Million EUR 34.49%
2014 12.58 Million EUR 4456.93%
2013 276.17 Thousand EUR 99.5%
2012 138.43 Thousand EUR 0.0%
2011 - EUR -100.0%
2010 49.25 Thousand EUR 146.26%
2009 20 Thousand EUR 0.0%

Peer Revenue Comparison of Formycon AG

Name Revenue Revenue Difference
BioNTech SE 3.81 Billion EUR 97.966%
CureVac N.V. 53.75 Million EUR -44.529%
Biotest Aktiengesellschaft 684.6 Million EUR 88.651%
Biotest Aktiengesellschaft 684.6 Million EUR 88.651%
BRAIN Biotech AG 55.33 Million EUR -40.41%
Heidelberg Pharma AG 9.85 Million EUR -688.079%
Medigene AG 6.03 Million EUR -1187.637%